Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region

M. Miura, Y. Miura, W. Sonoyama, T. Yamaza, S. Gronthos, S. Shi

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

The craniofacial region contains many specified tissues including bone, cartilage, muscle, blood vessels and neurons. Defect or dysfunction of the craniofacial tissue after post-cancer ablative surgery, trauma, congenital malformations and progressive deforming skeletal diseases has a huge influence on the patient's life. Therefore, functional reconstruction of damaged tissues is highly expected. Bone marrow-derived mesenchymal stem cells (BMMSCs) are one of the most well characterized postnatal stem cell populations, and considered to be utilized for cell-based clinical therapies. Here, the current understanding and the potential applications in craniofacial tissue regeneration of BMMSCs are reviewed, and the current limitations and drawbacks are also discussed.

LanguageEnglish
Pages514-522
Number of pages9
JournalOral Diseases
Volume12
Issue number6
DOIs
Publication statusPublished - Nov 2006

Keywords

  • Differentiation
  • Mesenchymal stem cell (MSC)
  • Tissue regeneration

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Dentistry(all)

Cite this

Miura, M. ; Miura, Y. ; Sonoyama, W. ; Yamaza, T. ; Gronthos, S. ; Shi, S. / Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region. In: Oral Diseases. 2006 ; Vol. 12, No. 6. pp. 514-522.
@article{edfdeff7c999442c860caaeb77ad1140,
title = "Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region",
abstract = "The craniofacial region contains many specified tissues including bone, cartilage, muscle, blood vessels and neurons. Defect or dysfunction of the craniofacial tissue after post-cancer ablative surgery, trauma, congenital malformations and progressive deforming skeletal diseases has a huge influence on the patient's life. Therefore, functional reconstruction of damaged tissues is highly expected. Bone marrow-derived mesenchymal stem cells (BMMSCs) are one of the most well characterized postnatal stem cell populations, and considered to be utilized for cell-based clinical therapies. Here, the current understanding and the potential applications in craniofacial tissue regeneration of BMMSCs are reviewed, and the current limitations and drawbacks are also discussed.",
keywords = "Differentiation, Mesenchymal stem cell (MSC), Tissue regeneration",
author = "M. Miura and Y. Miura and W. Sonoyama and T. Yamaza and S. Gronthos and S. Shi",
year = "2006",
month = "11",
doi = "10.1111/j.1601-0825.2006.01300.x",
language = "English",
volume = "12",
pages = "514--522",
journal = "Oral Diseases",
issn = "1354-523X",
publisher = "Wiley-Blackwell",
number = "6",

}

Miura, M, Miura, Y, Sonoyama, W, Yamaza, T, Gronthos, S & Shi, S 2006, 'Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region', Oral Diseases, vol. 12, no. 6, pp. 514-522. https://doi.org/10.1111/j.1601-0825.2006.01300.x

Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region. / Miura, M.; Miura, Y.; Sonoyama, W.; Yamaza, T.; Gronthos, S.; Shi, S.

In: Oral Diseases, Vol. 12, No. 6, 11.2006, p. 514-522.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region

AU - Miura, M.

AU - Miura, Y.

AU - Sonoyama, W.

AU - Yamaza, T.

AU - Gronthos, S.

AU - Shi, S.

PY - 2006/11

Y1 - 2006/11

N2 - The craniofacial region contains many specified tissues including bone, cartilage, muscle, blood vessels and neurons. Defect or dysfunction of the craniofacial tissue after post-cancer ablative surgery, trauma, congenital malformations and progressive deforming skeletal diseases has a huge influence on the patient's life. Therefore, functional reconstruction of damaged tissues is highly expected. Bone marrow-derived mesenchymal stem cells (BMMSCs) are one of the most well characterized postnatal stem cell populations, and considered to be utilized for cell-based clinical therapies. Here, the current understanding and the potential applications in craniofacial tissue regeneration of BMMSCs are reviewed, and the current limitations and drawbacks are also discussed.

AB - The craniofacial region contains many specified tissues including bone, cartilage, muscle, blood vessels and neurons. Defect or dysfunction of the craniofacial tissue after post-cancer ablative surgery, trauma, congenital malformations and progressive deforming skeletal diseases has a huge influence on the patient's life. Therefore, functional reconstruction of damaged tissues is highly expected. Bone marrow-derived mesenchymal stem cells (BMMSCs) are one of the most well characterized postnatal stem cell populations, and considered to be utilized for cell-based clinical therapies. Here, the current understanding and the potential applications in craniofacial tissue regeneration of BMMSCs are reviewed, and the current limitations and drawbacks are also discussed.

KW - Differentiation

KW - Mesenchymal stem cell (MSC)

KW - Tissue regeneration

UR - http://www.scopus.com/inward/record.url?scp=33750290856&partnerID=8YFLogxK

U2 - 10.1111/j.1601-0825.2006.01300.x

DO - 10.1111/j.1601-0825.2006.01300.x

M3 - Review article

VL - 12

SP - 514

EP - 522

JO - Oral Diseases

T2 - Oral Diseases

JF - Oral Diseases

SN - 1354-523X

IS - 6

ER -